
Stivmont AM 75mg/5mg/10mg Tablet SR
Marketer
Indoscot Healthcare LLP
Salt Composition
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Overview Stivmont AM 75mg/5mg/10mg Tablet SR
RespiClear AM 75mg/5mg/10mg Extended-Release Tablets are a multi-component medication for managing respiratory illnesses characterized by thick mucus. This formulation offers relief from productive coughs associated with conditions such as bronchial asthma, bronchitis, and the common cold. RespiClear AM should be ingested as directed by your physician, with or without food, adhering to the prescribed dosage and treatment duration. Treatment length depends on your response and condition. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Commonly reported side effects include nausea, indigestion, dry mouth, influenza-like symptoms, tiredness, and headache; most are transient. Report any concerning side effects promptly. Drowsiness and dizziness are potential effects; avoid driving or activities requiring alertness until you assess your response. Alcohol consumption should be avoided due to potential additive sleepiness. Prior to starting treatment, disclose any liver or kidney impairments to ensure appropriate dosage. Pregnancy, pregnancy planning, or breastfeeding should also be reported to your physician.
Primary Ingredients of Stivmont AM 75mg/5mg/10mg Tablet SR
No text provided. Please provide the text you wish to be rewritten.
Uses of Stivmont AM 75mg/5mg/10mg Tablet SR
Managing respiratory illnesses complicated by thick mucus.
Major Benefits of Stivmont AM 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Stivmont AM 75mg/5mg/10mg sustained-release tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Stivmont AM 75mg/5mg/10mg Tablet SR:
- Nausea
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Allergic reaction
- Sleepiness
- Flu-like symptoms
How to use Stivmont AM 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Stivmont AM 75mg/5mg/10mg Extended-Release tablets can be consumed with or without food, though consistent timing is recommended.
How Stivmont AM 75mg/5mg/10mg Tablet SR works:
Tri-Med 75/5/10 SR tablets combine ambroxol, levocetirizine, and montelukast to alleviate respiratory symptoms. Ambroxol, a mucolytic agent, facilitates mucus clearance by reducing its viscosity. Levocetirizine, an antihistamine, targets allergic rhinitis symptoms such as nasal discharge, lacrimation, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, diminishing airway and nasal inflammation, thus providing symptomatic relief.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Stivmont AM 75mg/5mg/10mg Tablet SR with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The extended-release Stivmont AM 75mg/5mg/10mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Stivmont AM 75mg/5mg/10mg tablet is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Stivmont AM 75mg/5mg/10mg sustained-release tablets might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when taking Stivmont AM 75mg/5mg/10mg SR tablets. Dosage modification may be necessary; physician consultation is advised. Stivmont AM 75mg/5mg/10mg SR tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Stivmont AM 75mg/5mg/10mg Tablet SR. A modified dosage of Stivmont AM 75mg/5mg/10mg Tablet SR may be necessary. Physician consultation is advised.
What if you forget to take Stivmont AM 75mg/5mg/10mg Tablet SR :
Should you forget to take a Stivmont AM 75mg/5mg/10mg sustained-release tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Stivmont AM 75mg/5mg/10mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
